Practically Speaking: Cabozantinib – another treatment in the medicine CABINET

To be added to the distribution list, please email: DDeCastro@southlake.ca

In this episode of MedOncNow, Dr. Simron Singh discusses the use of Cabozantinib in the managment of Extra-Pancreatic and Pancreatic NETs.  This is timely given we now have access to Cabozaninib through a company sponsored case by case access program for pretreated NETs patients. 

Key Opinion Leader: 

Simron Singh, MD, MPH, FRCPC
Staff Medical Oncologist, Sunnybrook Health Sciences Centre
Professor, University of Toronto

Host:
Shaqil Kassam MD. MSc. FRCPC
skassam@southlake.ca
Medical Oncologist
Stronach Regional Cancer Centre, Newmarket, Ontario 

Previous episodes: https://www.blogtalkradio.com/medoncnow

X- @medoncnow